Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Pioglitazone improves superoxide dismutase mediated vascular reactivity in the obese Zucker rat.

Dorafshar AH, Moodley K, Khoe M, Lyon C, Bryer-Ash M.

Diab Vasc Dis Res. 2010 Jan;7(1):20-7. doi: 10.1177/1479164109341688. Epub 2009 Oct 13.

PMID:
20368229
2.

Sleep duration and five-year abdominal fat accumulation in a minority cohort: the IRAS family study.

Hairston KG, Bryer-Ash M, Norris JM, Haffner S, Bowden DW, Wagenknecht LE.

Sleep. 2010 Mar;33(3):289-95.

3.

Evaluation of DLG2 as a positional candidate for disposition index in African-Americans from the IRAS Family Study.

Palmer ND, Mychaleckyj JC, Langefeld CD, Ziegler JT, Williams AH, Bryer-Ash M, Bowden DW.

Diabetes Res Clin Pract. 2010 Jan;87(1):69-76. doi: 10.1016/j.diabres.2009.10.015. Epub 2009 Nov 20.

4.

Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study.

Hanley AJ, Wagenknecht LE, Norris JM, Bryer-Ash M, Chen YI, Anderson AM, Bergman R, Haffner SM.

Diabetologia. 2009 Oct;52(10):2079-86. doi: 10.1007/s00125-009-1464-y. Epub 2009 Jul 31.

5.

Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort.

Wagenknecht LE, Scherzinger AL, Stamm ER, Hanley AJ, Norris JM, Chen YD, Bryer-Ash M, Haffner SM, Rotter JI.

Obesity (Silver Spring). 2009 Jun;17(6):1240-6. doi: 10.1038/oby.2009.4. Epub 2009 Feb 19.

6.

Association of plasma vitamin D levels with adiposity in Hispanic and African Americans.

Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, Bryer-Ash M, Norris JM.

J Clin Endocrinol Metab. 2009 Sep;94(9):3306-13. doi: 10.1210/jc.2009-0079. Epub 2009 Jun 23.

7.

Five-year change in visceral adipose tissue quantity in a minority cohort: the Insulin Resistance Atherosclerosis Study (IRAS) family study.

Hairston KG, Scherzinger A, Foy C, Hanley AJ, McCorkle O, Haffner S, Norris JM, Bryer-Ash M, Wagenknecht LE.

Diabetes Care. 2009 Aug;32(8):1553-5. doi: 10.2337/dc09-0336. Epub 2009 Jun 1.

8.

Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans.

Schmitz KJ, Skinner HG, Bautista LE, Fingerlin TE, Langefeld CD, Hicks PJ, Haffner SM, Bryer-Ash M, Wagenknecht LE, Bowden DW, Norris JM, Engelman CD.

Am J Hypertens. 2009 Aug;22(8):867-70. doi: 10.1038/ajh.2009.88. Epub 2009 May 14.

9.

A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS).

Rich SS, Goodarzi MO, Palmer ND, Langefeld CD, Ziegler J, Haffner SM, Bryer-Ash M, Norris JM, Taylor KD, Haritunians T, Rotter JI, Chen YD, Wagenknecht LE, Bowden DW, Bergman RN.

Diabetologia. 2009 Jul;52(7):1326-33. doi: 10.1007/s00125-009-1373-0. Epub 2009 May 9.

10.

Persistent hypoglycemia in a patient with diabetes taking etanercept for the treatment of psoriasis.

Cheung D, Bryer-Ash M.

J Am Acad Dermatol. 2009 Jun;60(6):1032-6. doi: 10.1016/j.jaad.2008.12.012. Epub 2009 Feb 13.

PMID:
19217693
11.

Association of the Kir6.2 E23K variant with reduced acute insulin response in African-Americans.

Palmer ND, Langefeld CD, Bryer-Ash M, Rotter JI, Taylor KD, Bowden DW.

J Clin Endocrinol Metab. 2008 Dec;93(12):4979-83. doi: 10.1210/jc.2008-0543. Epub 2008 Sep 16.

12.

Visceral fat and prevalence of hypertension among African Americans and Hispanic Americans: findings from the IRAS family study.

Foy CG, Hsu FC, Haffner SM, Norris JM, Rotter JI, Henkin LF, Bryer-Ash M, Chen YD, Wagenknecht LE.

Am J Hypertens. 2008 Aug;21(8):910-6. doi: 10.1038/ajh.2008.213. Epub 2008 Jun 19.

13.

Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study.

Palmer ND, Goodarzi MO, Langefeld CD, Ziegler J, Norris JM, Haffner SM, Bryer-Ash M, Bergman RN, Wagenknecht LE, Taylor KD, Rotter JI, Bowden DW.

Diabetes. 2008 Apr;57(4):1093-100. doi: 10.2337/db07-1169. Epub 2008 Feb 5.

14.

Association of the estrogen receptor-alpha gene with the metabolic syndrome and its component traits in African-American families: the Insulin Resistance Atherosclerosis Family Study.

Gallagher CJ, Langefeld CD, Gordon CJ, Campbell JK, Mychaleckyj JC, Bryer-Ash M, Rich SS, Bowden DW, Sale MM.

Diabetes. 2007 Aug;56(8):2135-41. Epub 2007 May 18. Erratum in: Diabetes. 2007 Oct;56(10):2650. Mychalecky, Josyf C [corrected to Mychaleckyj, Josyf C].

15.

Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans.

Hanley AJ, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, Rotter JI, Guo X, Chen YD, Bryer-Ash M, Norris JM, Haffner SM.

J Clin Endocrinol Metab. 2007 Jul;92(7):2665-71. Epub 2007 Apr 10.

PMID:
17426091
16.

[Effects of globular adiponectin, glucose and free fatty acid on AMPK and ACC phosphorylation in INS-1 beta cells].

Tong Y, Huang DS, Bryer-Ash M.

Beijing Da Xue Xue Bao Yi Xue Ban. 2006 Dec 18;38(6):609-13. Chinese.

17.

Focal adhesion kinase mediates cell survival via NF-kappaB and ERK signaling pathways.

Huang D, Khoe M, Befekadu M, Chung S, Takata Y, Ilic D, Bryer-Ash M.

Am J Physiol Cell Physiol. 2007 Apr;292(4):C1339-52. Epub 2006 Nov 29.

18.

Reduced expression of focal adhesion kinase disrupts insulin action in skeletal muscle cells.

Huang D, Khoe M, Ilic D, Bryer-Ash M.

Endocrinology. 2006 Jul;147(7):3333-43. Epub 2006 Mar 30.

PMID:
16574795
19.

Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents.

Goodarzi MO, Bryer-Ash M.

Diabetes Obes Metab. 2005 Nov;7(6):654-65. Review.

PMID:
16219009
20.

Point: Inpatient glucose management: the emperor finally has clothes.

Bryer-Ash M, Garber AJ.

Diabetes Care. 2005 Apr;28(4):973-5. Review. No abstract available.

PMID:
15793209
21.

Leptin increases hepatic insulin sensitivity and protein tyrosine phosphatase 1B expression.

Lam NT, Lewis JT, Cheung AT, Luk CT, Tse J, Wang J, Bryer-Ash M, Kolls JK, Kieffer TJ.

Mol Endocrinol. 2004 Jun;18(6):1333-45. Epub 2004 Feb 19.

PMID:
14976221
22.

Vascular endothelial growth factor inhibits mitogen-induced vascular smooth muscle cell proliferation.

Dorafshar AH, Angle N, Bryer-Ash M, Huang D, Farooq MM, Gelabert HA, Freischlag JA.

J Surg Res. 2003 Oct;114(2):179-86.

PMID:
14559444
23.

Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression.

Shimizu S, Ugi S, Maegawa H, Egawa K, Nishio Y, Yoshizaki T, Shi K, Nagai Y, Morino K, Nemoto K, Nakamura T, Bryer-Ash M, Kashiwagi A.

J Biol Chem. 2003 Oct 31;278(44):43095-101. Epub 2003 Aug 26.

24.

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome.

Ghazeeri G, Kutteh WH, Bryer-Ash M, Haas D, Ke RW.

Fertil Steril. 2003 Mar;79(3):562-6.

PMID:
12620440
25.

Genomes, transcriptomes, and proteomes: molecular medicine and its impact on medical practice.

Gerling IC, Solomon SS, Bryer-Ash M.

Arch Intern Med. 2003 Jan 27;163(2):190-8. Review.

PMID:
12546609
26.

Mechanism for differential effect of protein-tyrosine phosphatase 1B on Akt versus mitogen-activated protein kinase in 3T3-L1 adipocytes.

Shimizu S, Maegawa H, Egawa K, Shi K, Bryer-Ash M, Kashiwagi A.

Endocrinology. 2002 Dec;143(12):4563-9.

PMID:
12446583
27.

Focal adhesion kinase (FAK) regulates insulin-stimulated glycogen synthesis in hepatocytes.

Huang D, Cheung AT, Parsons JT, Bryer-Ash M.

J Biol Chem. 2002 May 17;277(20):18151-60. Epub 2002 Jan 23.

28.

Effects of adenovirus-mediated liver-selective overexpression of protein tyrosine phosphatase-1b on insulin sensitivity in vivo.

Wang J, Cheung AT, Kolls JK, Starks WW, Martinez-Hernandez A, Dietzen D, Bryer-Ash M.

Diabetes Obes Metab. 2001 Oct;3(5):367-80.

PMID:
11703427
29.

Evaluation of the patient with a suspected thyroid disorder.

Bryer-Ash M.

Obstet Gynecol Clin North Am. 2001 Jun;28(2):421-38. Review.

PMID:
11430185
30.

Human pancreatic islets transfected to produce an inhibitor of TNF are protected against destruction by human leukocytes.

Dobson T, Fraga D, Saba C, Bryer-Ash M, Gaber AO, Gerling IC.

Cell Transplant. 2000 Nov-Dec;9(6):857-65.

PMID:
11202571
31.

Early thyrotoxic thyroiditis after radiotherapy for tonsillar carcinoma.

Bryer-Ash M, Lodhi W, Robbins K, Morrison R.

Arch Otolaryngol Head Neck Surg. 2001 Feb;127(2):209-11.

PMID:
11177042
32.

Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in l6 myocytes and Fao hepatoma cells.

Egawa K, Maegawa H, Shimizu S, Morino K, Nishio Y, Bryer-Ash M, Cheung AT, Kolls JK, Kikkawa R, Kashiwagi A.

J Biol Chem. 2001 Mar 30;276(13):10207-11. Epub 2001 Jan 2.

33.

Glucose-dependent insulin release from genetically engineered K cells.

Cheung AT, Dayanandan B, Lewis JT, Korbutt GS, Rajotte RV, Bryer-Ash M, Boylan MO, Wolfe MM, Kieffer TJ.

Science. 2000 Dec 8;290(5498):1959-62.

35.

Comparative efficacy and potency of long-term therapy with glipizide or glyburide in patients with type 2 diabetes mellitus.

Kitabchi AE, Kaminska E, Fisher JN, Sherman A, Pitts K, Bush A, Bryer-Ash M.

Am J Med Sci. 2000 Mar;319(3):143-8.

PMID:
10746824
36.

Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus.

Cheung A, Kusari J, Jansen D, Bandyopadhyay D, Kusari A, Bryer-Ash M.

J Lab Clin Med. 1999 Aug;134(2):115-23.

PMID:
10444024
38.

Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders.

Mason AL, Xu L, Guo L, Munoz S, Jaspan JB, Bryer-Ash M, Cao Y, Sander DM, Shoenfeld Y, Ahmed A, Van de Water J, Gershwin ME, Garry RF.

Lancet. 1998 May 30;351(9116):1620-4. Erratum in: Lancet 1998 Jul 11;352(9122):152.

PMID:
9620716
39.

First report of recombination between the HLA-DR and HLA-DQ loci within a family.

Sullivan KA, Wolfe MA, Lopez M, Jaspan JB, Bryer-Ash M.

Hum Immunol. 1997 Sep 15;57(1):37-43.

PMID:
9438193
40.

NIDDM: new aspects of management.

Kitabchi AE, Bryer-Ash M.

Hosp Pract (1995). 1997 Mar 15;32(3):135-8, 143-4, 149-51 passim.

PMID:
9078977
41.

The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.

Jaspan JB, Sullivan K, Garry RF, Lopez M, Wolfe M, Clejan S, Yan C, Tenenbaum S, Sander DM, Ahmed B, Bryer-Ash M.

J Clin Endocrinol Metab. 1996 Jun;81(6):2271-9.

PMID:
8964863
42.

Conversion of pancreas transplants to FK 506 from CsA.

Tesi RJ, Bryer-Ash M, Jaspan J, Byer-Ashe M [corrected to Bryer-Ash M].

Transplant Proc. 1995 Dec;27(6):3032-3. No abstract available. Erratum in: Transplant Proc 1996 Apr;28(2):1128.

PMID:
8539828
43.

Amylin-mediated reduction in insulin sensitivity corresponds to reduced insulin receptor kinase activity in the rat in vivo.

Bryer-Ash M, Follett L, Hodges N, Wimalawansa S.

Metabolism. 1995 Jun;44(6):705-11.

PMID:
7783653
44.

Insulin-mediated increase in blood flow is impaired in the elderly.

Meneilly GS, Elliot T, Bryer-Ash M, Floras JS.

J Clin Endocrinol Metab. 1995 Jun;80(6):1899-903.

PMID:
7775638
45.

Modified method for the performance of glucose insulin clamp studies in conscious rats.

Cheung A, Bryer-Ash M.

J Pharmacol Toxicol Methods. 1994 Aug;31(4):215-20.

PMID:
7949378
46.

Bis(maltolato)oxovanadium(IV) attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats.

Bhanot S, Bryer-Ash M, Cheung A, McNeill JH.

Diabetes. 1994 Jul;43(7):857-61.

PMID:
8013747
47.
48.

Vanadyl sulfate prevents fructose-induced hyperinsulinemia and hypertension in rats.

Bhanot S, McNeill JH, Bryer-Ash M.

Hypertension. 1994 Mar;23(3):308-12.

PMID:
8125555
50.

Characterization of insulin-stimulated seryl/threonyl protein kinases in rat skeletal muscle.

Hei YJ, McNeill JH, Sanghera JS, Diamond J, Bryer-Ash M, Pelech SL.

J Biol Chem. 1993 Jun 25;268(18):13203-13.

Supplemental Content

Loading ...
Support Center